We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

13 hedge funds and large institutions have $7.43M invested in Virtus Biotech ETF in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.21% less ownership

Funds ownership: 39.65% → 32.44% (-7.2%)

19% less funds holding

Funds holding: 16 → 13 (-3)

27% less capital invested

Capital invested by funds: $10.2M → $7.43M (-$2.79M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$47K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25K
3
Morgan Stanley
Morgan Stanley
New York
+$155

Top Sellers

Rank Fund Capital Flow
1
SMG
Smart Money Group
Texas
-$1.41M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.14M
3
TC
Telemus Capital
Michigan
-$200K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$26.6K
5
FWM
Focused Wealth Management
New York
-$15.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$3.96M -$26.6K -515 -0.7%
SMG
2
Smart Money Group
Texas
$1.64M -$1.41M -27,366 -46%
FAIM
3
Financial Advocates Investment Management
Washington
$498K – – –
Stifel Financial
4
Stifel Financial
Missouri
$389K -$5.16K -100 -1%
LPL Financial
5
LPL Financial
California
$337K -$6.03K -117 -2%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$254K +$25K +484 +11%
Morgan Stanley
7
Morgan Stanley
New York
$106K +$155 +3 +0.1%
NFG
8
Next Financial Group
Texas
$103K – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$61K – – –
Bank of America
10
Bank of America
North Carolina
$46K +$47K +911 New
FWM
11
Focused Wealth Management
New York
$20K -$15.5K -300 -43%
SWA
12
SOA Wealth Advisors
New York
$7K – – –
UBS Group
13
UBS Group
Switzerland
$2K -$3.46K -67 -69%
Citadel Advisors
14
Citadel Advisors
Florida
– -$1.14M -21,306 Closed
TC
15
Telemus Capital
Michigan
– -$200K -3,750 Closed
IA
16
IFP Advisors
Florida
– -$4K -71 Closed
CFB
17
Cullen/Frost Bankers
Texas
– -$4K -70 Closed

BBP Hedge Fund Activity: Q3 2021 in Review

13 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2021, worth a combined $7.43M — down 27% from $10.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BBP and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was Bank of America, opening a new position worth an estimated $47K. The largest seller was Smart Money Group, cutting an estimated $1.41M.

  • 13 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2021, down from 16 in Q2 2021.
  • Funds reported $7.43M of Virtus Biotech ETF stock for Q3 2021, down 27% quarter-over-quarter.
  • 1 fund opened new Virtus Biotech ETF positions in Q3 2021 and 4 closed out, a net change of -3 holders.
  • The largest Virtus Biotech ETF buyer in Q3 2021 was Bank of America, an estimated $47K added.
  • The largest Virtus Biotech ETF seller in Q3 2021 was Smart Money Group, an estimated $1.41M sold.

Based on aggregated 13F filings for Q3 2021.